A recent survey commissioned by The Ohio State University Comprehensive Cancer Center -- Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC -- James) focused on Americans' perceptions of testicular cancer. The results suggest more can be done to educate the public about the disease, which affects nearly 10,000 adults in the United States each year according to the American Cancer Society.
The OSUCCC -- James survey found that only 13% of U.S. adults -- just over 1 in 10 -- correctly identified testicular cancer as most commonly affecting men under 40. This is significant, as the disease is most prevalent among men between the ages of 20 and 40.
Additionally, two-thirds (65%) of respondents believe an evaluation should be part of an annual exam after age 40. However, cancer experts note that self-exams are most relevant between the ages of 20 and 40.
"In my experience, a lot of men are surprised that testicular cancer is most common among young men," said Shawn Dason, MD, urologic oncologist at the OSUCCC -- James. "It's something you're just not expecting in your twenties or thirties. A lot of young men's focus might be on developing their career, their day-to-day life. That's a very different track of mind than perhaps your health."
Survey results In the survey of 1,008 respondents aged 18 and older, 6 in 10 (63%) correctly identified that testicular cancer is often curable if caught early, and just over half (54%) correctly said that monthly self-checks should be conducted.
"We are really fortunate in testicular cancer that the vast majority of patients are diagnosed at an early stage," said Dason, also an associate clinical professor of urology at Ohio State College of Medicine. "That means the vast majority of patients are actually diagnosed before the cancer has had an opportunity to spread to other parts of the body."
Younger Americans, age 18-29, and adults, age 30-49, were more likely than their older counterparts to say that testicular cancer affects fertility (68% and 61%, respectively). However, younger adults were also more likely than all other age groups to incorrectly agree with the statement that testicular cancer symptoms are always painful (18%).
"Testicular cancer does not typically come with painful symptoms," said Dason. "That's why routine self-exams are so important to detect any lumps or changes to the testicle. If you feel something out of the ordinary, like a lump or bump, or if the testicle changes in size, call your doctor."
Survey methodology
This survey was conducted by SSRS on its Opinion Panel Omnibus platform. The SSRS Opinion Panel Omnibus is a national, twice-per-month, probability-based survey. Data collection was conducted from May 2 -- May 5, 2025, among a sample of 1,008 respondents. The survey was conducted via web (n=978) and telephone (n=30) and administered in English. The margin of error for total respondents is +/-3.6 percentage points at the 95% confidence level. All SSRS Opinion Panel Omnibus data are weighted to represent the target population of U.S. adults ages 18 or older.
To learn more about cancer treatment and clinical trials at the OSUCCC -- James, visit cancer.osu.edu[1] or call 1-800-293-5066.
A recent survey commissioned by The Ohio State University Comprehensive Cancer Center -- Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC -- James) focused on Americans' perceptions of testicular cancer. The results suggest more can be done to educate the public about the disease, which affects nearly 10,000 adults in the United States each year according to the American Cancer Society.
The OSUCCC -- James survey found that only 13% of U.S. adults -- just over 1 in 10 -- correctly identified testicular cancer as most commonly affecting men under 40. This is significant, as the disease is most prevalent among men between the ages of 20 and 40.
Additionally, two-thirds (65%) of respondents believe an evaluation should be part of an annual exam after age 40. However, cancer experts note that self-exams are most relevant between the ages of 20 and 40.
"In my experience, a lot of men are surprised that testicular cancer is most common among young men," said Shawn Dason, MD, urologic oncologist at the OSUCCC -- James. "It's something you're just not expecting in your twenties or thirties. A lot of young men's focus might be on developing their career, their day-to-day life. That's a very different track of mind than perhaps your health."
Survey results In the survey of 1,008 respondents aged 18 and older, 6 in 10 (63%) correctly identified that testicular cancer is often curable if caught early, and just over half (54%) correctly said that monthly self-checks should be conducted.
"We are really fortunate in testicular cancer that the vast majority of patients are diagnosed at an early stage," said Dason, also an associate clinical professor of urology at Ohio State College of Medicine. "That means the vast majority of patients are actually diagnosed before the cancer has had an opportunity to spread to other parts of the body."
Younger Americans, age 18-29, and adults, age 30-49, were more likely than their older counterparts to say that testicular cancer affects fertility (68% and 61%, respectively). However, younger adults were also more likely than all other age groups to incorrectly agree with the statement that testicular cancer symptoms are always painful (18%).
"Testicular cancer does not typically come with painful symptoms," said Dason. "That's why routine self-exams are so important to detect any lumps or changes to the testicle. If you feel something out of the ordinary, like a lump or bump, or if the testicle changes in size, call your doctor."
Survey methodology
This survey was conducted by SSRS on its Opinion Panel Omnibus platform. The SSRS Opinion Panel Omnibus is a national, twice-per-month, probability-based survey. Data collection was conducted from May 2 -- May 5, 2025, among a sample of 1,008 respondents. The survey was conducted via web (n=978) and telephone (n=30) and administered in English. The margin of error for total respondents is +/-3.6 percentage points at the 95% confidence level. All SSRS Opinion Panel Omnibus data are weighted to represent the target population of U.S. adults ages 18 or older.
To learn more about cancer treatment and clinical trials at the OSUCCC -- James, visit cancer.osu.edu[1] or call 1-800-293-5066.
Read more https://www.sciencedaily.com/releases/2025/06/250616040226.htm